| Erik Charles Kofler, DO | |
|
401 W Poplar St, Walla Walla, WA 99362-2846 | |
| (855) 600-5163 | |
| Not Available |
| Full Name | Erik Charles Kofler |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 10 Years |
| Location | 401 W Poplar St, Walla Walla, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518387075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | OP60758853 (Washington) | Primary |
| 207L00000X | Anesthesiology | DOL.OL.60473440 (Washington) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Mary Medical Center | Walla walla, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Service- Washington | 0840279758 | 149 |
News Archive
Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had Hepatitis C.
Inhibiting fatty acid synthesis in brain cancer cells may offer a new option to treat about 50 percent of deadly glioblastomas that are driven by amplified signaling of the epidermal growth factor receptor (EGFR), according to a first-of-its-kind study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.
Researchers from Columbia University Medical Center, New York State Psychiatric Institute, and NewYork-Presbyterian reported that an odor identification test may prove useful in predicting cognitive decline and detecting early-stage Alzheimer's disease.
› Verified 9 days ago
| Entity Name | Providence Health & Service- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508118555 PECOS PAC ID: 0840279758 Enrollment ID: O20090717000201 |
News Archive
Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had Hepatitis C.
Inhibiting fatty acid synthesis in brain cancer cells may offer a new option to treat about 50 percent of deadly glioblastomas that are driven by amplified signaling of the epidermal growth factor receptor (EGFR), according to a first-of-its-kind study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.
Researchers from Columbia University Medical Center, New York State Psychiatric Institute, and NewYork-Presbyterian reported that an odor identification test may prove useful in predicting cognitive decline and detecting early-stage Alzheimer's disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erik Charles Kofler, DO 401 W Poplar St, Walla Walla, WA 99362-2846 Ph: () - | Erik Charles Kofler, DO 401 W Poplar St, Walla Walla, WA 99362-2846 Ph: (855) 600-5163 |
News Archive
Newcastle University researchers analysed a small clinical trial of losartan, a drug normally prescribed for hypertension, on 14 patients in Spain, who had Hepatitis C.
Inhibiting fatty acid synthesis in brain cancer cells may offer a new option to treat about 50 percent of deadly glioblastomas that are driven by amplified signaling of the epidermal growth factor receptor (EGFR), according to a first-of-its-kind study by researchers at UCLA's Jonsson Comprehensive Cancer Center.
A major increase in innovative concepts for exciting therapeutic and preventive new products in Australia has led to an expansion of GZP's activities Down Under, to better support clients in their efforts to take their programs to the US Food and Drug Administration.
Researchers from Columbia University Medical Center, New York State Psychiatric Institute, and NewYork-Presbyterian reported that an odor identification test may prove useful in predicting cognitive decline and detecting early-stage Alzheimer's disease.
› Verified 9 days ago
Dr. Karl Robert Eckhardt, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 8 Oconner Ln, Walla Walla, WA 99362 Phone: 509-522-0479 Fax: 509-522-0512 | |
Paul C Zievers, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 401 W Poplar St, Walla Walla, WA 99362 Phone: 509-529-1284 Fax: 509-522-1798 | |
Daniel James Doran, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 W Poplar St Ste 1440, Walla Walla, WA 99362 Phone: 855-600-5163 | |
Dr. Kurt J Schlicker, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 401 W Poplar St, Walla Walla, WA 99362 Phone: 509-529-1284 | |
Dr. Timothy G Caudill, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 W Poplar St, Walla Walla, WA 99362 Phone: 509-529-1284 | |
Dr. Christopher Lee Aldrich, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 W Poplar St, Walla Walla, WA 99362 Phone: 509-525-3320 |